that the SUMO-activating and -conjugating enzymes, as well as the SUMO-deconjugating enzymes, were first described (Figure 1 ; reviewed in Melchior, 2000). As with ubiquitin, the C-terminal carboxyl group of SUMO appears to be activated by adenylation, in this case by the The first is the existence of a recognizable consensus sequence-⌿KxE, where ⌿ is an aliphatic residueeukaryotic proteins are subject. Ubiquitin is the most familiar of the proteinaceous protein modifiers, and the surrounding the substrate lysine(s) that is sumoylated. No such consensus sequence has ever been found for enzymology of its activation and transfer to target molecules has been studied extensively for over two deubiquitination targets, and for many substrates, the ubiquitin conjugation enzymes show a remarkable indiffercades. Much more recently, a sizeable group of ubiquitin-related proteins have come to light, often as a result ence toward the particular lysine that is to be modified. The second unusual aspect of sumoylation is that the of genome sequencing efforts. Many of these proteins consist of ubiquitin-related domains that are stably built E1 and E2 enzymes (together with ATP and SUMO) appear to be sufficient in vitro for relatively robust modifiinto larger structures, and in some cases it is likely these domains derive from independent protein lineages that cation of proteins at precisely the lysines that are preferred in vivo. For ubiquitin, an additional factor, called have converged on the ubiquitin fold because of its intrinsic structural utility. However, at least a dozen disan E3 or ubiquitin-protein ligase, is almost always necessary for efficient substrate ubiquitination, both in vitro tinct ubiquitin-like proteins (Ubls) do precisely what ubiquitin is so well known for doing: they form covalent and in vivo. An E3 has been defined as "an enzyme that binds, directly or indirectly, specific protein substrates attachments to other macromolecules. 
one or two (or any) zinc ions and to verify that it folds into a RING-like conformation.
In the most complete of the three new studies, Johnson and Gupta (2001) provide convincing evidence that Siz1 is an E3-like protein that promotes SUMO attachment to specific proteins. Recombinant E1, E2, and Siz1 purified from E. coli are able to synthesize polySUMO chains from monomeric SUMO; more importantly, since the significance of SUMO chains is unknown, the same set of proteins can catalyze sumoylation of a highly purified septin preparation from yeast. Siz1 binds to the E2 Ubc9 and appears to bind, directly or indirectly, to septins (Takahashi et al., 2001). In vivo, Siz1 is specifically required for septin modification whereas Siz2 is needed for the sumoylation of an unidentified ‫72ف‬ kDa protein. Thus, all the criteria defining an E3 are satisfied. interactions deriving from the E2 versus E3 components What led all these investigators to the idea that Siz1, in E2/E3 ubiquitin-conjugation complexes. The SUMO Siz2, and PIAS1 might be E3-like factors was the modest pathway may be shifted toward the end of the spectrum similarity of a conserved internal segment of these prowhere a substantial part of the binding energy comes teins to the RING finger, a motif that defines the largest from the E2. Having the E2 play a larger role in substrate subfamily of ubiquitin E3s (Hershko and Ciechanover, recognition might be the more "primitive" situation 1998). RING fingers bind a pair of zinc atoms in a distincamong the Ubl ligation systems since in the ancestral tive "cross-brace" arrangement of coordinating Cys and modification system(s), E2-like proteins probably tarHis residues, creating a globular domain that can digeted substrates without an E3. E3-like factors likely rectly bind E2s. However, the Siz/PIAS RING (SP-RING) arose later, allowing for enhanced or expanded specificlacks two of the cysteines that are conserved in all ities-or in some cases taking over the task of substrate known RING E3s, so it remains to be demonstrated that discrimination almost entirely (Hochstrasser, 2000). it has the same general structure as a classical RING. It Analysis of additional SUMO substrates and other Ubl is noteworthy that mutation of several zinc-coordinating conjugation systems will be necessary to test these concysteines in the BRCA1 RING finger does not abolish jectures. 
